person · Reporting owner

Kantor Jeffrey A

Disclosed activity across 1 company

Tapewire entity: 172097
SEC CIK: 0001542939

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Macy's, Inc.M · Entity 3820	Chief Merchandising Officer	October 27, 2017	November 06, 2017

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Macy's, Inc.

Report date October 27, 2017 · Filed November 06, 2017 · Amendment

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	28,419	Reported balance Holding disclosure · report date 2017-10-27 · row 1 Amendment: may correct only part of an earlier disclosure. 1 source row Row 1 · Balance 28,419
Common StockSEC Table I · non-derivative	IndirectBy Wife	6	Reported balance Holding disclosure · report date 2017-10-27 · row 2 Amendment: may correct only part of an earlier disclosure. 1 source row Row 2 · Balance 6
Common StockSEC Table I · non-derivative	IndirectBy 401(k) Plan	6,326	Reported balance Holding disclosure · report date 2017-10-27 · row 3 Amendment: may correct only part of an earlier disclosure. 1 source row Row 3 · Balance 6,326
Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $24.85 · Expires 2018-03-21	Direct	Not disclosed	Reported balance Holding disclosure · report date 2017-10-27 · row 4 Amendment: may correct only part of an earlier disclosure. 1 source row Row 4 · Balance Not disclosed F1: Options became exercisable as follows: 5,096 on March 21, 2009; 5,095 on March 21, 2010; 5,096 on March 21, 2011 and 5,095 on March 21, 2012.
Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $20.89 · Expires 2020-03-19	Direct	Not disclosed	Reported balance Holding disclosure · report date 2017-10-27 · row 5 Amendment: may correct only part of an earlier disclosure. 1 source row Row 5 · Balance Not disclosed F2: Options became exercisable as follows: 2,803 on March 19, 2011; 2,803 on March 19, 2012; 2,803 on March 19, 2013 and 2,803 on March 19, 2014.
Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $23.43 · Expires 2021-03-25	Direct	Not disclosed	Reported balance Holding disclosure · report date 2017-10-27 · row 6 Amendment: may correct only part of an earlier disclosure. 1 source row Row 6 · Balance Not disclosed F3: Options became exercisable as follows: 7,023 on March 25, 2012; 7,022 on March 25, 2013; 7,022 on March 25, 2014; 7,022 on March 25, 2015.
Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $39.84 · Expires 2022-03-23	Direct	Not disclosed	Reported balance Holding disclosure · report date 2017-10-27 · row 7 Amendment: may correct only part of an earlier disclosure. 1 source row Row 7 · Balance Not disclosed F4: Options became exercisable as follows: 6,138 on March 23, 2013; 6,137 on March 23, 2014; 6,137 on March 23, 2015 and 6,137 on March 23, 2016.
Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $41.67 · Expires 2023-03-19	Direct	Not disclosed	Reported balance Holding disclosure · report date 2017-10-27 · row 8 Amendment: may correct only part of an earlier disclosure. 1 source row Row 8 · Balance Not disclosed F5: Options became exercisable as follows: 7,408 on March 19, 2014; 7,407 on March 19, 2015; 7,407 on March 19, 2016 and 7,407 on March 19, 2017.
Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $58.92 · Expires 2024-03-28	Direct	Not disclosed	Reported balance Holding disclosure · report date 2017-10-27 · row 9 Amendment: may correct only part of an earlier disclosure. 1 source row Row 9 · Balance Not disclosed F6: Options became exercisable as follows: 4,720 on March 28, 2015; 4,719 on March 28, 2016; 4,719 on March 28, 2017 and 4,719 on March 28, 2018.
Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $63.65 · Expires 2025-03-27	Direct	Not disclosed	Reported balance Holding disclosure · report date 2017-10-27 · row 10 Amendment: may correct only part of an earlier disclosure. 1 source row Row 10 · Balance Not disclosed F7: Options became exercisable as follows: 6,810 on March 27, 2016; 6,809 on March 27, 2017; 6,809 on March 27, 2018 and 6,809 on March 27, 2019.
Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $43.42 · Expires 2026-03-23	Direct	Not disclosed	Reported balance Holding disclosure · report date 2017-10-27 · row 11 Amendment: may correct only part of an earlier disclosure. 1 source row Row 11 · Balance Not disclosed F8: Options became exercisable as follows: 11,486 on March 23, 2017; 11,485 on March 23, 2018; 11,485 on March 23, 2019 and 11,485 on March 23, 2020.
Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $28.17 · Expires 2027-03-24	Direct	Not disclosed	Reported balance Holding disclosure · report date 2017-10-27 · row 12 Amendment: may correct only part of an earlier disclosure. 1 source row Row 12 · Balance Not disclosed F9: Options became exercisable as follows: 24,428 on March 24, 2018; 24,427 on March 24, 2019; 24,427 on March 24, 2020 and 24,427 on March 24, 2021.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Not disclosed	Reported balance Holding disclosure · report date 2017-10-27 · row 13 Amendment: may correct only part of an earlier disclosure. 1 source row Row 13 · Balance Not disclosed F11: Each restricted stock unit represents a contingent right to receive one share of Macy's Common Stock. F10: The Restricted Stock Units vest on August 25, 2020.

Filing footnotes · ownership attribution and instrument terms

F1: Options became exercisable as follows: 5,096 on March 21, 2009; 5,095 on March 21, 2010; 5,096 on March 21, 2011 and 5,095 on March 21, 2012.

F2: Options became exercisable as follows: 2,803 on March 19, 2011; 2,803 on March 19, 2012; 2,803 on March 19, 2013 and 2,803 on March 19, 2014.

F3: Options became exercisable as follows: 7,023 on March 25, 2012; 7,022 on March 25, 2013; 7,022 on March 25, 2014; 7,022 on March 25, 2015.

F4: Options became exercisable as follows: 6,138 on March 23, 2013; 6,137 on March 23, 2014; 6,137 on March 23, 2015 and 6,137 on March 23, 2016.

F5: Options became exercisable as follows: 7,408 on March 19, 2014; 7,407 on March 19, 2015; 7,407 on March 19, 2016 and 7,407 on March 19, 2017.

F6: Options became exercisable as follows: 4,720 on March 28, 2015; 4,719 on March 28, 2016; 4,719 on March 28, 2017 and 4,719 on March 28, 2018.

F7: Options became exercisable as follows: 6,810 on March 27, 2016; 6,809 on March 27, 2017; 6,809 on March 27, 2018 and 6,809 on March 27, 2019.

F8: Options became exercisable as follows: 11,486 on March 23, 2017; 11,485 on March 23, 2018; 11,485 on March 23, 2019 and 11,485 on March 23, 2020.

F9: Options became exercisable as follows: 24,428 on March 24, 2018; 24,427 on March 24, 2019; 24,427 on March 24, 2020 and 24,427 on March 24, 2021.

F10: The Restricted Stock Units vest on August 25, 2020.

F11: Each restricted stock unit represents a contingent right to receive one share of Macy's Common Stock.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 24, 2017 Filed Mar 28, 2017 21:21 UTC	Macy's, Inc. M · Entity 3820	GrantOptions to Purchase Common Stock · Derivative	97,709	$0.00 Strike: $28.17	$0.00	Disclosure SEC source: 0000794367-17-000027 · primary_doc.xml · derivative · entry 2 Kantor Jeffrey A · CIK 0001542939 · Chief Stores and HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,709 Underlying: Common Stock · 97,709 shares Expires 2027-03-24 F2 · derivative.exercise_date: Grant to reporting person of options to purchase 97,709 shares of common stock under the Issuer's Amended and Restated 2009 Omnibus Incentive Compensation Plan. The options become exercisable in 25% increments on March 24, 2018, March 24, 2019, March 24, 2020 and March 24, 2021. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.